581. Risks versus Benefits of Metronidazole Use for the Prevention of Acute GVHD in Allogeneic Stem Cell Transplant Recipients

BACKGROUND: Currently, acute graft versus host disease (aGVHD) prophylaxis in hematopoietic stem cell transplants (HSCT) varies amongst different institutions. There is a lack of data supporting the use of metronidazole for aGVHD prophylaxis in HSCT. To further investigate if metronidazole has an ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Mary T, Monogue, Marguerite, Patel, Hetalkumari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776744/
http://dx.doi.org/10.1093/ofid/ofaa439.775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776744/
http://dx.doi.org/10.1093/ofid/ofaa439.775

Ejemplares similares